# FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women

> **NCT00625404** · PHASE3 · COMPLETED · sponsor: **FHI 360** · enrollment: 2120 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Truvada
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00625404
- **Lead sponsor:** FHI 360
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-08
- **Final completion:** 2013-01
- **Target enrollment:** 2120 (ACTUAL)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00625404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00625404, "FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00625404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*